Transition Bio

Transition Bio, Inc. was founded with the vision of becoming a global leader in the discovery, analysis, and modulation of biomolecular condensates, leveraging its unique technological capabilities to create a wide range of drug development opportunities in a hypothesis-free manner.Transition Bio, Inc. utilizes droplet microfluidics and a protein biophysics platform to characterize condensates with unprecedented precision, mapping them in molecular detail. We refer to this as Condensomics™.